Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7034653 | 0.64 | MAOA (0.32) | MAOA | |
| Hydrochloric Acid SCHEMBL6858046 | 0.64 | NPC1 (0.40) | DRD2DRD4 | |
| Hydrochloric Acid SCHEMBL6862750 | 0.64 | NPC1 (0.40) | DRD2DRD4 | |
| Hydrochloric Acid SCHEMBL995805 | 0.64 | NPC1 (0.40) | DRD2DRD4 | |
| Hydrochloric Acid SCHEMBL6862741 | 0.64 | NPC1 (0.40) | DRD2DRD4 | |
| Hydrochloric Acid SCHEMBL995808 | 0.64 | NPC1 (0.40) | DRD2DRD4 | |
| Hydrochloric Acid SCHEMBL6858052 | 0.64 | NPC1 (0.40) | DRD2DRD4 | |
| SCHEMBL18920311 | 0.63 | BCHE (0.38) | MAOADRD2DRD4 | |
| SCHEMBL28907906 | 0.62 | MAOA (0.62) | MAOA | |
| SCHEMBL7034170 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6800701-B2 | USING COORDINATION CATALYSTS | DOW GLOBAL TECHNOLOGIES INC. | 2004-10-05 | — | — | US | disclosed |
| US-20030216529-A1 | Polycyclic, fused ring compounds, metal complexes and polymerization process | DOW GLOBAL TECHNOLOGIES LLC | 2003-11-20 | — | — | US | disclosed |
| US-6613921-B2 | Ligand comprising at least: a cyclopentadienyl ring, a 6,7,or 8 membered ring other than a 6-carbon aromatic ring, and an aromatic ring; said 6, 7, or 8 membered ring, is fused to both the cyclopentadienyl and the aromatic ring | DOW GLOBAL TECHNOLOGIES INC. | 2003-09-02 | — | — | US | disclosed |
| US-20020062011-A1 | Polycyclic, fused ring compounds, metal complexes and polymerization process | DOW GLOBAL TECHNOLOGIES LLC | 2002-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216529-A1 | Polycyclic, fused ring compounds, metal complexes and polymerization process | PIN1, ZC3H18, ORC3 | MAOA 1784/4885DRD2 631/4885DRD4 307/4885 |
| US-20020062011-A1 | Polycyclic, fused ring compounds, metal complexes and polymerization process | PIN1, ZC3H18, ORC3 | MAOA 1784/4885DRD2 631/4885DRD4 307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.